Skip to ContentGo to accessibility page

Chapter 18

Unfolding Case Study

1.
c. Based on the American Heart Association Blood Pressure Category criteria, the client has hypertension stage 2 (systolic blood pressure 140 mm Hg or higher and diastolic blood pressure 90 mm Hg or higher).
2.
c. Renal function tests are likely to be ordered for Hahn to evaluate the function of her kidneys because both hypertension and diabetes can cause kidney damage. Kidney function should also be evaluated before starting pharmacological treatment for hypertension.
3.
c. ACE inhibitors, such as enalapril, can cause hyperkalemia (an elevated serum potassium level), so the nurse should advise the client not to use potassium-containing salt substitutes.
4.
b. The client who smokes should be advised to stop smoking to aid in blood pressure control and reduce the risk for coronary artery disease. Other nonpharmacologic treatments for hypertension include weight reduction, salt restriction, exercising 30–40 minutes four times/week, and limiting alcohol intake.
5.
d. Constipation is an adverse effect of verapamil, so the nurse instructs Hahn to increase her daily fiber intake to help reduce this effect.
6.
a. In a heart-healthy diet, the client should reduce her intake of red meat. This statement indicates a need for further teaching.

Review Questions

1.
d. Hypertension stage 2 is classified as a systolic blood pressure of 140 mm Hg or higher or a diastolic blood pressure of 90 mm Hg or higher.
2.
b. Benazepril is an ACE inhibitor and may be used alone or in combination with other drugs in the management of hypertension and heart failure. A therapeutic effect of the medication is a normal blood pressure reading; 126/76 mm Hg falls within the AHA guidelines for normal blood pressure.
3.
a. Nadolol is a nonselective beta-adrenergic blocker used to treat hypertension and other cardiac disease processes. Nadolol inhibits beta 1 and beta 2. Blockade of beta 2 receptors in the lungs causes bronchospasm; thus, nadolol is contraindicated in clients with asthma.
4.
b. 0.1 g = 100 m g . 100 m g ÷ 50 m g = 2 t a b l e t s .
5.
d. Transdermal nitroglycerin is prescribed as a maintenance medication for stable angina, which takes 30–60 minutes for therapeutic effects to begin. The patch should be applied around the same time every day and worn for 12–14 hours and then removed for 10–12 hours to avoid client tolerance.
6.
d. Verapamil is a calcium channel blocker. Grapefruit juice increases blood levels of verapamil by inhibiting its metabolism. The excess amount of medication can intensify the medication’s hypotensive effect, placing the client at an increased risk for syncopal episodes.
7.
b. Hydrochlorothiazide is a thiazide diuretic and can deplete potassium levels in the body. Clients should eat foods rich in potassium. Clients should monitor themselves for signs of hypokalemia such as fatigue, tachycardia, muscle weakness, and leg cramps.
8.
b. 6.25 m g ÷ 3.125 m g = 2 t a b l e t s p e r d o s e .
9.
d. Losartan is a selective and competitive angiotensin II receptor blocker (ARB) at the angiotensin I receptor.
10.
a. Carvedilol is a beta-adrenergic blocker and slows the heart rate. A side effect of carvedilol is bradycardia. The health care provider should be notified of bradycardia in a client before the administration of the drug.
Citation/Attribution
Reuse and redistribution of this content in digital or print format:
  • This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's prior written permission.
  • This book uses the Creative Commons Attribution-NonCommercial-ShareAlike License, which means that you can reuse and modify the material only for noncommercial purposes, must attribute OpenStax, and must distribute any derivative works under the same license.
  • Any commercial printing of this textbook, including using a local or custom printer, must be approved by OpenStax, and proper citation provided.
  • OpenStax-copyrighted images, activities, assessments, and similar components of this book are subject to the same licensing – CC-BY-NC-SA. They can be used for noncommercial purposes with attribution. Commercial use requires permission.
  • Permission requests: Anyone who intends to incorporate this content (including text, images, and other components) into large language models, use it in AI offerings, use it commercially (including in print), and/or has questions about another use case is welcome to complete our reuse request form.
Attribution information
  • If you are redistributing all or part of this book in a noncommercial print format, then you must include on every physical page the following attribution:

    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction

  • If you are redistributing all or part of this book in a noncommercial digital format, then for every page that includes OpenStax content, you must license the derivative work under the same CC-BY-NC-SA license as the original, and include on every digital page view the following attribution:

    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction

Citation information

The information below includes the information needed to generate citations in most major styles (APA, MLA, etc.); you must reformat and organize the information as needed to fit the requirements of the style. Use the information below to generate a citation. We recommend using a citation tool such as this one.

© Apr 23, 2026 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo, and Rice University name, and Rice University logo trademarks, or wordmarks are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.